Wednesday, March 30, 2022 7:43:00 AM
It is much easier to search for IgG and IgM as "markers" to show that an individual has been exposed to COVID and/or has been vaccinated and their body has reacted to that vaccination.
It is much harder to say that this level of Nabs gives you this level of protection.
Without the research to prove the statement above, Immunopass could be viewed as a dangerous weapon in the hands of the individual. Someone might be tempted to interpret their resulting Nabs levels as providing a level of protection not backed by medical research, simply because that research hasn't been done yet.
This was my hesitation from the beginning with Immunopass. Yes, now everyone is aware that the "science" behind masks and even the vaccinations was faulty at best, but regardless, that "science" pushed the Government's agenda.
Immunopass, however, is a level of "science" that would push against and opposite to the Government's agenda.
Great product that would empower the individual to know more about their own body, but not something the government wants in the hands of the people at this time.
Based on this Government's agenda (mandates and control over the population) "For Research Use Only" is the best place for Axim's Nabs test kit at this time.
Once the research is complete, then Axim's Nabs test kit could move into the medical diagnostics market (ie: to be used by medical professionals to rapidly diagnose Nabs levels).
Finally, the test kit could someday ultimately find its way into the retail (over-the-counter) market, but that could be years down the road.
First-in-Class and Light years ahead of the competition is unfortunately a distant future product when it comes to over the counter sales.
For now, RUO for the Nabs test kit, and emphasis on the DED line of rapid test kits in the hands of medical professionals, is the way to go.
I should be hearing back today from my friend's daughter (actually, niece that he raised as a daughter) regarding the potential for the DED line of test kits. I will post her thoughts on those products when they come in.
Godspeed.
These opinions are my own and are not intended as investment advice. If you feel that my statements are "Pumping", Propaganda, or manipulative in any way, please refrain from trading and seek medical treatment immediately.
Recent AXIM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/15/2024 09:05:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 08:44:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 09:06:24 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/13/2024 08:14:24 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/22/2024 08:53:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:24:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM